MedPath
FDA Approval

Posaconazole

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
June 2, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Posaconazole(18 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Posaconazole

Product Details

NDC Product Code
42023-195
Application Number
ANDA208768
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
June 2, 2022
Code: 6TK1G07BHZClass: ACTIBQuantity: 18 mg in 1 mL
SULFOBUTYLETHER .BETA.-CYCLODEXTRINInactive
Code: 2PP9364507Class: IACTQuantity: 400 mg in 1 mL
EDETATE DISODIUMInactive
Code: 7FLD91C86KClass: IACTQuantity: 0.2 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath